cipla board of directors
Other roles include membership of various advisory boards including HIV Vaccine Trials Network, USA, Massachusetts General Hospital and Institute of Medicine of the National Academies, USA, and the Joint United Nations Programme on HIV/AIDS (UNAIDS) 90-90-90 initiative to end the HIV epidemic, among others. Prior to returning to India, he led the Washington office of McKinsey and founded its Minneapolis office. Ms Naina Lal Kidwai is an Independent Non-Executive Director of the Company. A recipient of many awards and honours in India, she was awarded the Padma Shri by the Government of India for her contribution to trade and industry. Mark has a strong track record in senior strategic, operational and financial management roles in large listed and unlisted companies. Mr S. Radhakrishnan retired from the position of Whole-time Director in November, 2017 and thereafter continues as the Non-Executive Director of the Company. Mr Umang Vohra joined Cipla Limited in 2015 and has been the MD & GCEO of the Company since September 2016. Umang Vohra has been Managing Director and Global Chief Executive Officer (MD &GCEO) of Cipla since September 2016. Ms Kidwai possesses rich experience in the areas of banking and finance. As Executive Vice-Chairperson of Cipla, Samina focuses on board and governance issues, in addition to furthering Cipla’s strategic priorities through key global partnerships, corporate culture, hiring the right talent, and public advocacy. He represents the second generation of Cipla’s founding family. Recognised as the promoter face of Cipla, Samina has been feted for her diverse work experience and business knowledge. Ms Hamied has built a top-class leadership pipeline for the Company as it continues to spread its wings globally. Board of Directors Company Policies Products Anti-Retrovirals. For 2 consecutive years - 2018 and 2019 – Fortune India named her among the most powerful women in business. He is involved in many philanthropic causes and is on the Board of Piramal Foundation. 13/11/2014 Quarterly Results. Emmanuel became the Chief Executive Officer of Cipla Quality Chemical Industries Ltd until 2013 when he was appointed Executive Chairman of the Company, a position he holds to-date. Committees of the Board number of meetings of the Board and Board committees The Board currently has six committees namely the Audit Committee the Nomination andRemuneration Committee the Corporate Social Responsibility Committee the StakeholdersRelationship Committee the Investment and Risk Management Committee and the Operationsand Administrative Committee. From affordable drugs in HIV to enabling one of the world’s largest portfolio of drugs and devices in inhalation therapy, his pioneering work and immense contribution to healthcare have been celebrated around the world. Mr. M. K. Hamied is a science graduate from Bombay University and has vast and varied experience in all functions of the Company including production, technical areas, quality management and general administration.He is Non-Executive Vice-Chairman of the Company and represents the second generation of Cipla’s founding family. Cipla - Board Meeting Intimation for Notice Of The Board Meeting . Mr Ashok Sinha is an Independent Non-Executive Director of the Company. Corporate Social Responsibility Committee, Charter of the Nomination and Remuneration Committee, Charter of the Corporate Social Responsibility Committee, Charter of the Stakeholders Relationship Committee, Charter of the Investment and Risk Management Committee, Charter of the Operations and Administrative Committee. Directors employees and external stakeholders can report their genuine concerns eitherin writing or by email to the Chairperson of the Ethics Committee or to the Chief InternalAuditor at ethics@cipla.com or to the Chairperson of the Audit Committee ataudit.chairman@ cipla.com . 29/05/2015 Audited Results & Dividend. She has authored 3 books, “Survive or Sink - An Action Agenda for Sanitation, Water, Pollution and Green Finance”, “Contemporary Banking in India” and “30 Women in Power: Their Voices, Their Stories.” She possesses rich experience in the areas of banking and finance. He is involved in many philanthropic causes and is also on the Board of Piramal Foundation. Ms Punita Lal is an Independent Non-Executive Director of the Company. Get detailed reports on Cipla financial results, CSR and company policy and corporate governance for the year. A world-renowned scientist, Dr Hamied obtained his PhD in organic chemistry in 1960 from the University of Cambridge under the tutelage of the Nobel laureate Lord Alexander Todd. He spent 33 years in BPCL and served on the Board of BPCL for 15 years – first as Director (Finance) for 10 years from 1996 and then as its Chairman and Managing Director for 5 years from August 2005. New CIPLA President and a new Member of the Board of Directors Jun 6, 2019 | Announcements , News We are pleased to announce that one of our partners, Robert Dean was elected president of the Connecticut Intellectual Property Law Association (CIPLA). As a senior business leader, she has many accolades to her credit, including being chosen as one of India’s top 20 Businesswomen by Business Today in 2006, and being awarded Corporate Woman of the Year in 2009 by the FICCI Women’s Organisation. He retired as Chairman of McKinsey, India after 34 years at McKinsey, the last ten were in India. She is one of the Government of India’s representatives on the BRICs Business Council and the INDO-ASEAN Business Council. In 2017, she received the ‘Most Powerful Women in Business’ award from Business Today. The longest-serving Director General of All India Management Association, a former member of All India Council of Technical Education and All India Board of Management Studies, Mr. Khurana has made exceptional contributions in learning and practice of Management in India. Mr. BFSL is the finest financial service provider, specialised in the areas of Stock Broking, Commodity Broking, Equity Research, … Mr Zainulbhai co-edited the book, ‘Reimagining India’ which featured 60 authors including prominent businessmen, academics, economists, authors and journalists. Managing Director & Global CEO: 5: Mr. S Radhakrishnan: Non Exe.Non Ind.Director: 6: Mr. Ashok Sinha: Independent Director: 7: Dr. Peter Mugyenyi: Independent Director: 8: Mr. Adil Zainulbhai: Independent Director: 9: Ms. Punita Lal: Independent Director: 10: Ms. Naina Lal Kidwai: Independent Director Stay informed - subscribe to our newsletter. She was appointed as an Executive Director of the Company w.e.f. Mr M. K. Hamied is Non-Executive Vice-Chairman of the Company and represents the second generation of Cipla’s founding family. He retired as Chairman of McKinsey, India after 34 years at McKinsey, and the last 10 in India. Mr. George Baguma is a founding Director and was also the founding Chief Commercial Officer at Cipla Quality Chemicals Ltd from 2000 to 2005. Samina joined Cipla in the year 2011 as a member of management team. 12/02/2015 Quarterly Results. Mr S. Radhakrishnan is a Non-Executive Director of the Company and is a qualified Chartered Accountant. He is the Chairman of the Quality Council of India (QCI) and Board Advisor to US India strategic partnership forum. Naina Lal Kidwai. Ms Samina Hamied is the Executive Vice-Chairperson of the Company, and represents the third generation of Cipla’s founding family. Mr S Radhakrishnan retired from his position of Whole-Time Director in November 2017 and thereafter continues as a Non-Executive Director of the Company. Dr Y K Hamied is the Non-Executive Chairman of the Company. In 2013, he was named as one of India’s 25 Greatest Global Living Legends by NDTV, and in 2014, the University of Cambridge honoured him with a DSc the highest honour that the University can bestow. Cipla Limited is a Public incorporated on 17 August 1935. In 2017, Columbia University’s Mailman School of Public Health conferred the ‘Public Health Hero Award’ on Dr Hamied, and in 2018 India Today named him one of ‘20 Global Indians’ who have challenged convention and created history. Previously, he served as Chief Executive Officer of Cipla North America, a global pharmaceutical company based in Mumbai, India. A recipient of many awards and honours in India, she was awarded the Padma Shri by the Government of India for her contribution to Trade and Industry. Mr Zainulbhai has graduated in Mechanical Engineering from the Indian Institute of Technology. He is the Chairman of the Quality Council of India (QCI) and Board Advisor to US India strategic partnership forum. He is a science graduate from Bombay University. Cipla Board Of Directors - … Dr Mugyenyi is an Ugandan paediatrician, researcher and specialist on HIV/AIDS and related conditions. Adil Zainulbhai. A football fan, Kamil Hamied is known to be a calm and quiet person who wants to do something for society, like his uncle Yusuf. He joined Cipla Medpro in 2013, prior to which he served as the Vice President and Managing Director of Mylan in South Africa and as the Marketing Director of AstraZeneca in China. Dr Peter Mugyenyi is an Independent Non-Executive Director of the Company. He has a wealth of experience, competencies and expertise from his leadership journey as the Chairman and Managing Director of Bharat Petroleum Corporation Ltd. (BPCL). He possesses rich experience in financial, commercial, legal and allied areas. Ms Punita Lal is an Independent Non-Executive Director of the Company. Mr S. Radhakrishnan is a Non-Executive Director of the Company and is a qualified Chartered Accountant. He retired as Executive Vice- Chairman of the Company on 31st March, 2014 and is continuing as a Non- Executive Vice-Chairman since 1st April, 2014. Managing Director & Global CEO. Cipla has appointed Samina Vaziralli as Executive Director on its board. He possesses rich experience in financial, commercial, legal and allied areas. Mr Zainulbhai graduated in Mechanical Engineering from the Indian Institute of Technology. His research and publications cover a wide spectrum of HIV/AIDS, related diseases and other medical conditions. 24,010,130. Its authorized share capital is Rs. Its authorized share capital is Rs. Crew has more than 30 years of experience in the generic and branded pharmaceutical industries. She is currently practising as an independent Strategy and Marketing Consultant. Mr S. Radhakrishnan retired from the position of Whole-time Director in November, 2017 and thereafter continues as the Non-Executive Director of the Company. Mr Umang Vohra joined Cipla in 2015, and has been Managing Director and Global Chief Executive Officer of Cipla since September 2016. Get board of directors for cipla ltd here. Independent Director: Ashok Sinha: Independent Director: Geena Malhotra: Global Head: Kedar Upadhye: Global Chief Financial Officer: M K Hamied: Vice Chairman: Naina Lal Kidwai: Independent Director: … He possesses rich experience in financial, commercial, legal and allied areas. Appointed to the board in October 2019. Ms Kidwai has authored three books; “Survive or Sink - An Action Agenda for Sanitation, Water, Pollution and Green Finance”, “Contemporary Banking in India” and “30 Women in Power: Their Voices, Their Stories.”. He is a Bachelor of Medicine and Surgery (MB ChB), Fellow of the Royal College of Physicians of Ireland (FRCPI), Fellow of the Royal College of Physicians (Edinburgh) (FRCP Edin), Doctor of Science [ScD(h)], is a Ugandan Paediatrician, researcher and specialist on HIV/AIDS and related conditions. She worked in the UK and the US with leading global firm Goldman Sachs before joining the Cipla leadership team in 2011 as a member of the management team. Dr Mugyenyi has been a Principal Investigator on dozens of landmark research projects, some of which were funded by the National Institutes of Health (NIH), European Union, WHO and the Medical Research Council (MRC). Cipla Health Limited is a Public incorporated on 27 August 2015. A science graduate from Bombay University, Mr Hamied has vast and varied experience in all functions of the Company including production, technical areas, quality management and general administration. He is the Chairman of the Quality Council of India (QCI) and Board Advisor to the US India strategic partnership forum. An alumna of the London School of Economics, she has in the past worked in UK and the US with the leading global firm Goldman Sachs before joining the Cipla leadership team in 2011. Cipla Health Limited is a Public incorporated on 27 August 2015. He is the Executive Director of Joint Clinical Research Centre, Kampala – a centre of excellence in medical research, training and healthcare. A qualified chartered accountant, Mr S Radhakrishnan is a Non-Executive Director of the Company. Mr M K Hamied is the Non-Executive Vice-Chairman of the Company and represents the second generation of Cipla’s founding family. He joined Cipla Medpro in 2013, prior to which he served as the Vice President and Managing Director of Mylan in South Africa and as the Marketing Director of AstraZeneca in China. She is a B.A. Dr Mugyenyi has been a Principal Investigator on dozens of landmark research projects some of them funded by National Institutes of Health (NIH), European Union, WHO and Medical Research Council (MRC). As Executive Vice-Chairperson of Cipla, Samina focuses on board and governance issues, in addition to furthering Cipla’s strategic priorities through key global partnerships, corporate culture, hiring the right talent, and public advocacy. Ms Punita Lal is an Independent Non-Executive Director of the Company. Stock To Watch. Lamivudine, Zidovudine & Nevirapine Tablets Lamivudine and Zidovudine Tablets Efavirenz Tablets 600mg Lamivudine and Tenofovir Disoproxil Fumarate Tablets Nevirapine Tablets 200mg Efavirenz, Lamivudine & … Board of Directors ROBERT E. BROWN, JR. , Director, Chair of the Compensation Committee, and Member of the Nominating and Corporate Governance Committee Mr. Brown has been a member of the Board since June 2013 and has served as a director of the Company’s operating subsidiary, ANIP Acquisition Company d/b/a ANI Pharmaceuticals, Inc. since July 2010. He is also a recipient of award from TMG (Technology Media Group) for Customer Management. He oversaw the growth of Westside and other Trent formats from one-store operation in 1998 to over a hundred stores in 2012. Managing Director & Global Chief Executive Officer, © Copyright 2019 Cipla Inc. All rights reserved, © Copyright 2019 Cipla Inc. All rights reserved. He is also on the Board of our Ugandan subsidiary i.e. Dr Hamied has been an insightful R&D leader, a courageous industry captain, and an outspoken statesman of global pharma. She has been instrumental in driving the Company’s current transformation agenda. Other roles include membership of various advisory boards including HIV Vaccine Trials Network, USA, Massachusetts General Hospital and Institute of Medicine of the National Academies, USA and the Joint United Nations Programme on HIV/AIDS (UNAIDS), 90-90-90 initiative to end the HIV epidemic, among others. M K Hamied. With an MBA from the University of Wales, Paul has worked across Europe, Asia and North America before serving in leadership roles in South Africa. Board diversity. Board Of Directors; Committees of the Board; Investor Resources; Shareholding Pattern; Intimation to stock Exchanges; Unclaimed Data; Investor Contact; Disclaimer; Cipla Foundation. After gaining degrees in engineering, marketing and finance, Mr Vohra worked with Eicher Motors, PepsiCo and Dr Reddy’s Laboratories. He has also been conferred with the India Chief Financial Officer Award 2001 for Information and Knowledge Management by the Economic Intelligence Unit (EIU) India and American Express. 100,000,000 and its paid up capital is Rs. Board Of Directors; Committees of the Board; Investor Resources; Shareholding Pattern; Intimation to stock Exchanges; Unclaimed Data; Investor Contact; Disclaimer; Cipla Foundation. An MBA from Harvard Business School, she makes regular appearance on listings by Fortune and others of international women in business. Ms Samina Hamied is the Executive Vice-Chairperson of the Company, and represents the third generation of Cipla’s founding family. He is also on the Board of Reliance Industries, Larsen & Toubro as well as the Chairman of Network18 Media and Investment Limited and TV18 Broadcast Limited. Hamied is Non-Executive Chairman of the Company, and represents the second generation of Cipla’s founding family. Cipla Quality Chemical Industries Limited as an Independent Non–Executive Director. He possesses rich experience in financial, commercial, legal and allied areas. He is also on the Board of Reliance Industries Limited, Larsen & Toubro Limited, Chairman of Network18 Media & Investment Limited and TV18 Broadcast Limited. Mr Adil Zainulbhai is an Independent Non-Executive Director and Lead Independent Director of the Company. Cipla Quality Chemical Industries Limited as an Independent Non – Executive Director. Through his previous roles in India and the US, he has built a distinguished career spanning almost two decades with deep understanding and experience of various aspects of the global pharmaceutical business. Recognised as an action-oriented industry leader, Mr Vohra is a firm believer in the power of agile business models, disruptive technologies, data-driven analytics and a future-ready workforce with a view to making a difference to the lives of patients.
Loctite Vinyl, Fabric & Plastic Flexible Adhesive Reviews, Pudding Meaning In Kannada, Under Armour Tops, The Night Of The Long Knives, Property For Sale In Chandigarh Sector 22, Dangar Island Weather, Dores/aldourie Forest Walk,